Your browser doesn't support javascript.
loading
HIV-1 env gene mutations outside the targeting probe affects IPDA efficiency.
Zhou, Zehua; Zhang, Xinyu; Wang, Meiyu; Jiang, Fei; Tong, Jincheng; Nie, Jianhui; Zhao, Chenyan; Zheng, Haifa; Zhang, Zhen; Shi, Penghui; Fan, Weiguang; Wang, Youchun; Huang, Weijin.
Afiliación
  • Zhou Z; The Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, Sichuan, China.
  • Zhang X; Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, No. 31 Huatuo Street, Daxing District, Beijing 102629, China.
  • Wang M; Beijing Minhai Biotechnology Co., Ltd., Beijing, China.
  • Jiang F; Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, No. 31 Huatuo Street, Daxing District, Beijing 102629, China.
  • Tong J; College of Life Science, Jilin University, Changchun 130012, China.
  • Nie J; Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, No. 31 Huatuo Street, Daxing District, Beijing 102629, China.
  • Zhao C; Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Zheng H; Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, No. 31 Huatuo Street, Daxing District, Beijing 102629, China.
  • Zhang Z; Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, No. 31 Huatuo Street, Daxing District, Beijing 102629, China.
  • Shi P; Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, No. 31 Huatuo Street, Daxing District, Beijing 102629, China.
  • Fan W; Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, No. 31 Huatuo Street, Daxing District, Beijing 102629, China.
  • Wang Y; Beijing Minhai Biotechnology Co., Ltd., Beijing, China.
  • Huang W; Infection Division, the People's Hospital of Baoding, 608 Dongfeng East Road, Lianchi District, Baoding, Hebei 071000, China.
iScience ; 27(6): 109941, 2024 Jun 21.
Article en En | MEDLINE | ID: mdl-38812543
ABSTRACT
The intact proviral DNA assay (IPDA) based on droplet digital PCR was developed to identify intact proviral DNA and quantify HIV-1 latency reservoirs in patients infected with HIV-1. However, the genetic characteristics of different HIV-1 subtypes are non-consistent due to their high mutation and recombination rates. Here, we identified that the IPDA based on the sequences features of an HIV-1 subtype could not effectively detect different HIV-1 subtypes due to the high diversity of HIV-1. Furthermore, we demonstrated that mutations in env gene outside the probe binding site affect the detection efficiency of IPDA. Since mutations in env gene outside the probe binding site may also lead to the formation of stop codons, thereby preventing the formation of viruses and ultimately overestimating the number of HIV-1 latency reservoirs, it is important to address the effect of mutations on the IPDA.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: IScience Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: IScience Año: 2024 Tipo del documento: Article